Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 3 of about 3   

Articles published

NVS 95.04 +0.27 (0.28%)
price chart
Roche Building On Its Strengths
With other drugs like Zelboraf and T-DM1 on the way (Zelboraf is approved, T-DM1 likely will be in 2013), Roche looks poised to stretch its lead on Novartis (NVS), Sanofi, and AstraZeneca in oncology. What's more, while Regeneron's (REGN) Eylea may ...
PFIZER INC. : Summary Notice Of Pendency Of Class Action
NEW YORK, July 30, 2012 /PRNewswire/ -- YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Southern District of New York, that the above-captioned litigation ...
Related articles »  
The Tech-heavy NASDAQ Down The Most Among Three Key Indexes; Apple Inc ...
At last check, the tech-heavy NASDAQ Composite (INDEXNASDAQ:.IXIC) was down -0.75% to 2,943.36, floating in a range of 2,939.73 - 2,957.02.
Related articles »